Obermatt
See Similar Stocks →

IRIDEX

NAQ:IRIX · US4626841013
Health Care Equipment & SuppliesSmall

360

69
Profit price61
Owner Earnings Yield1
Dividend Yield1
Price/Sales100
EV / Gross Profit91
Price/Book89
Return on Capital43
Cash Return on Capital21
Return on Equity39
EBIT Margin60
Gross Profitability84
Accruals45
Owner Earnings Margin52
Sales growth18
Profit growth43
Reinvestment5
Price momentum66
Debt load34
Refinancing90
Debt Payback1
Liquidity89
Analyst ratings100
Opinion Changes50
Price Target Upside93
Market mood11
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

IRIDEX doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded1989
Employees101
Websiteiridex.com
ISINUS4626841013
Last UpdateApr 2, 2026
Index & Theme
OphthalmologyHealth DiagnosticsBiomedical EngineeringSurgeryBiotechnologyManufacturingMedical Device

Description

IRIDEX Corporation (IRIDEX), an ophthalmic medical technology company, focuses on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma, and retinal diseases.…

Analysis

Middle-of-the-road

IRIDEX Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
78
2023202420252026

All-time high

88

Jan 2023

All-time low

18

Jan 2024

Average rank

64

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
100
89
93
95
Price/Earnings
93
52
52
52
Price/Book
89
20
49
62
Dividend Yield
1
1
1
1
Value (overall)
98
51
61
71

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare IRIDEX with its peers
Glaukos
NYQ:GKOS
31
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
KORU Medical Systems
NAQ:KRMD
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Alphatec
NSQ:ATEC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Intuitive Surgical
NSQ:ISRG
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Outset Medical
NSQ:OM
38
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →